The phenotype and antigenic specificity of cells secreting interleukin (IL) 4, IL-6, and interferon 'y was studied in mice during primary and secondary immune responses. T lymphocytes were the major source of interferon 'y, whereas non-B/non-T cells were the dominant source of IL-4 and IL-6 in the spleens of immunized animals. Cytokinesecreting non-B/non-T cells expressed surface receptors for IgE and/or IgG types II/Ill. Exposing these cells to antigenspecific IgE or IgG in vivo (or in vitro) "armed" them to release IL-4 and IL-6 upon subsequent antigenic challenge. These findings suggest that non-B/non-T cells may represent the "natural immunity" analogue of CD4+ T helper type 2 cells and participate in a positive feedback loop involved in the perpetuation of T helper type 2 cell responses.
IL-4 and IL-6 in the spleens of immunized animals. Cytokinesecreting non-B/non-T cells expressed surface receptors for IgE and/or IgG types II/Ill. Exposing these cells to antigenspecific IgE or IgG in vivo (or in vitro) "armed" them to release IL-4 and IL-6 upon subsequent antigenic challenge. These findings suggest that non-B/non-T cells may represent the "natural immunity" analogue of CD4+ T helper type 2 cells and participate in a positive feedback loop involved in the perpetuation of T helper type 2 cell responses.
Immunoregulatory cytokines play an important role in determining the nature and strength of the immune system's response to pathogens, autoantigens, and tumor cells (1, 2) . Cytokines are commonly classified as being either T helper type 1 (Thl) [interferon (IFN) y and interleukin (IL) 2] or T helper type 2 (Th2) (IL-4, IL-5, IL-6, and IL-10), based on original studies involving cloned murine CD4+ T-cell subsets (3) . These two classes of cytokines exert distinct and, in some cases, antagonistic effects. Thl cytokines promote cellmediated immunity, whereas Th2 cytokines facilitate humoral immune responses (3) . Moreover, Th2 cytokines such as IL-4 and IL-10 can inhibit the production of IL-2 and IFN-,y (4-6), while IFN-y can interfere with the maturation of naive CD4+ T cells into Th2 cells (5, 7) .
The order and abundance with which Thl and Th2 cytokines are secreted in vivo have been studied in a variety of settings. Immune responses dominated by IFN-,y confer protection to hosts challenged with agents such as Leishmania major and Candida albicans, while responses dominated by IL-4 and related cytokines are protective against infection with the helminth Trichuris muris (8) (9) (10) (11) (12) .
Although the production of both Thl and Th2 cytokines is commonly associated with CD4+ T lymphocytes (3, 13) . Indeed, the phenotype of the cell(s) that are predominantly responsible for producing IL-4, IL-6, and IFN--y in immunized animals has not been established.
In an effort to determine which cells are the predominant producers of these cytokines after immunization, sensitive and specific cytokine ELIspot assays were developed to detect individual cells producing IL-4, IL-6, and IFN--y in vivo. These ELIspot assays have been used to monitor the number of cells spontaneously secreting cytokines in freshly harvested bone marrow, spleen, and lymph nodes and to detect the production of cytokines by single cells after in vivo and in vitro stimulation with antigen or mitogen (26) (27) (28) For experiments shown in Table 2 , cells were treated with 2.4G2 to prevent nonspecific antibody binding and then incubated with FITC-labeled anti-CD4, anti-CD8a, anti-CD23, and anti-B220 antibodies. The cell suspension was washed twice and then mixed with anti-FITC-coated magnetic beads (Advanced Magnetics, Cambridge, MA) as described (29 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. hemocyanin in CFA. After a 1-h incubation, cells were washed three times in medium and assayed for cytokine production in the presence of OVA (20 jig/ml), TNP-OVA (20 ,ug/ml), or medium.
For in vivo experiments, unimmunized 3-month-old BALB/c mice were injected i.v. with 10 ,tg of monoclonal anti-TNP IgE, monoclonal anti-TNP IgG, or PBS. After 24 h, a single-cell suspension was prepared from the spleens of these mice in RPMI 1640 medium supplemented with 5% fetal calf serum and analyzed for cytokine production. Cytokine-Specific ELIspot Assays. Ninety-six-well nitrocellulose-backed microtiter plates (Millipore) were coated with anti-IL-6 (clone MP5-20F3; PharMingen) at 10 ,ug/ml, anti-IL-4 (clone BVD6-24G2; Endogen, Cambridge, MA) at 10 ,tg/ml, or anti-IFN-^y (clone RA6a2; Lee Biomolecular Laboratories, San Diego) at 10 ,Lg/ml in 0.1 M sodium carbonate (pH 9.6) for 3 h at room temperature as described (26, 27, 29) . The plates were then blocked with PBS containing 5% (wt/ vol) bovine serum albumin for 1 h and washed extensively with PBS containing 0.05% Tween 20.
Serial dilutions of a single-cell suspension, starting with 105-106 cells per well, were incubated on the plate for 5 h at 37°C in a humidified 5% C02/95% air incubator. In some experiments, soluble OVA or TNP-OVA (20 ,ug/ml) was added to the wells for the duration of the assay. Preliminary experiments showed that this concentration of antigen induced optimal cytokine production in vitro. The plates were then washed with PBS/Tween and overlaid with biotinylated anti-IL-6 (clone MP5-32cll; PharMingen) at 1 jig/ml, anti-IL-4 (clone llBil) at 1 ,ug/ml, or anti-IFN--y (clone XMG-1.2; PharMingen) at 1 ,ug/ml overnight at 4°C. Plates were washed again, treated with a 1:2000 dilution of avidin-conjugated alkaline phosphatase (Vector Laboratories) for 2 h, and washed again.
The cytokine secreted by single cells was visualized by the addition of a solution of BCIP/NBT (Kirkegaard & Perry Laboratories). This solution yields a purple precipitate in the presence of phosphatase. The colorimetric reaction was halted after 30 min by washing with water, and spots were enumerated under x40 magnification. The dilution of cells yielding optimal numbers of spots per well was used to calculate the total number of cytokine-secreting cells per sample (26, 27, 29) .
Statistical Analysis. Statistical significance was determined by using a two-tailed t test unless otherwise specified.
RESULTS
Phenotype of Cytokine-Producing Cells Freshly Harvested from Immunized Mice. BALB/c mice were immunized with 25 ,ug of OVA in CFA. B, T, and non-B/non-T cells were purified by cell sorting from the spleens of these animals either 10 days after primary stimulation or 4 days after secondary antigenic challenge. Each cell population (>98% pure) was analyzed immediately for spontaneous cytokine production by ELIspot assay. The absolute number of IL-6-producing cells was substantially greater than the number of IL-4-producing cells, which in turn exceeded the frequency of IFN-y-producing cells. As seen in Table 1 , T lymphocytes accounted for virtually all of the IFN-y-producing cells but were only 40% of the IL-4-and 12% of the IL-6-producing cells in the spleens of animals sacrificed 10 days after immunization. The remaining cytokine-producing cells were primarily of the CD4-, CD8-, B220-phenotype (non-B/non-T cells). An even larger fraction of the IL-4-and IL-6-producing cells from animals 4 days after booster injection had the non-B/non-T phenotype. In these populations, 85% of the IL-4-and 94% of the IL-6-producing cells were non-B/non-T cells, while the IFN-yproducing cells remained predominantly T cells.
Effect that spleen cells from immunized mice can be triggered to release additional IL-4 and IL-6 when exposed to antigen in vitro (29, 30) . This allowed us to examine whether cytokine production by non-B/non-T cells was antigen-dependent. ELIspot assays were performed on spleen cells and non-B/ non-T cells in the presence or absence of soluble OVA.
The number of non-B/non-T cells secreting IL-4 and IL-6 increased 3-to 4-fold when splenocytes from OVA-immunized but not naive BALB/c mice were incubated with soluble OVA (Table 2) . A similar effect was observed when non-B/non-T cells from mice immunized and given booster injections with OVA were studied. This response was antigen-specific, since spleen cells from OVA-immunized mice did not release additional cytokine when cultured with an unrelated antigen (such as TNP-keyhole limpet hemocyanin, data not shown). These experiments also demonstrate that the frequency of non-B/non-T cells spontaneously producing IL-4 and IL-6 is greater in immunized mice than naive donors. As seen in Table 3 (Fig. 1) . Monoclonal anti-TNP IgE was particularly effective, inducing an antigen-dependent 3-to 4-fold increase in the number of cells releasing IL-4 and IL-6. A series of negative controls showed that this response was specific; OVA did not induce these cells to release cytokine nor did TNP-OVA stimulation of cells pretreated with control IgG or IgE antibodies (Fig. 1) .
Further studies were performed to determine whether cells exposed to circulating anti-TNP IgE and IgG in vivo could acquire specificity for TNP-OVA (as measured by cytokine release). Unimmunized BALB/c mice were injected with monoclonal anti-TNP IgG or anti-TNP IgE. As seen in Fig. 2 , spleen cells from these mice acquired the ability to release IL-4 and IL-6 when exposed to TNP-OVA in vitro, while cells from Three-month-old BALB/c mice were immunized and given a booster injection as described in Table 1 . Non-B/non-T cells were isolated, stained for FcR expression, and isolated by cell sorting. The resultant >98% pure cell populations were analyzed for cytokine production in medium alone (-) mice that received control monoclonal antibodies did not. This enhancement was particularly striking in mice injected with monoclonal anti-TNP IgE. The degree of enhancement for IL-4 production was greater than that for IL-6 production.
DISCUSSION
The experiments reported here establish several important principles concerning antigen-induced cytokine production. 10 ,ug of monoclonal anti-TNP IgG, or PBS. After 24 h, a single-cell suspension prepared from the spleens of these mice was analyzed for cytokine production as described in Fig. 1 (38) .
It has been shown (19, 34, 35) when reexposed to the same antigen. This series of events could be responsible for maintaining the cycle of cytokine/ antibody production characteristic of Th2-associated immune responses.
